文献速递临床试验与 GCP真实世界研究与卫生经济

生活照护专员对骨科创伤患者疼痛管理及阿片类药物相关结局的影响:随机对照试验研究方案

The effect of a Life Care Specialist on pain management and opioid-related outcomes among patients with orthopedic trauma: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-11-27

本研究为一项随机对照试验方案,计划纳入200例骨科创伤患者,随机分为生活照护专员(LCS)干预组或标准治疗对照组,在术后2、6、12周评估阿片类药物使用量(吗啡毫克当量)、疼痛评分及患者满意度等结局,旨在明确LCS干预对阿片类药物利用、疼痛控制及患者满意度的影响。

要点

  • LCS为新型医疗岗位,负责教育患者阿片类药物风险、减量使用、安全处置及伤害减少策略。
  • LCS还教授患者基于行为的疼痛管理策略,利用应对与心理韧性技术。
  • 主要评估指标包括阿片类药物利用(吗啡毫克当量)、疼痛评分及患者满意度。

核心结论

  • 该随机对照试验将提供LCS干预有效性和可行性的科学及临床证据,并初步揭示哪些患者从LCS干预中获益最大。

研究设计与样本

  • 研究为随机对照试验,计划在城区一级创伤中心纳入200例骨科创伤患者,随机分为LCS干预组或标准治疗对照组。
  • 所有患者在术后立即接受全面的健康社会决定因素和物质使用调查作为基线,并在术后2、6、12周进行随访评估。

主要发现

  • 目前尚无结果数据报告;方案计划评估阿片类药物利用(吗啡毫克当量)、疼痛评分、其他物质使用、客观活动记录仪指标、患者报告结局及患者对阿片类药物风险与误用理解调查。

关键数值与推荐

  • 原文未报告关键数值与推荐。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出,关于个体化、多模式、非药物、行为为基础的疼痛管理干预在高风险人群(包括骨科创伤患者)中阿片类药物相关风险缓解作用的数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Orthopedic trauma patients face complex pain management needs and are frequently prescribed opioids, leaving them at-risk for prolonged opioid use. To date, post-trauma pain management research has placed little emphasis on individualized risk assessments for misuse and systematically implementing non-pharmacologic pain management strategies. Therefore, a community-academic partnership was formed to design a novel position in the healthcare field (Life Care Specialist (LCS)), who will educate patients on the risks of opioids, tapering usage, safe disposal practices, and harm reduction strategies. In addition, the LCS teaches patients behavior-based strategies for pain management, utilizing well-described techniques for coping and resilience. This study aims to determine the effects of LCS intervention on opioid utilization, pain control, and patient satisfaction in the aftermath of orthopedic trauma. METHODS: In total, 200 orthopedic trauma patients will be randomized to receive an intervention (LCS) or a standard-of-care control at an urban level 1 trauma center. All patients will be assessed with comprehensive social determinants of health and substance use surveys immediately after surgery (baseline). Follow-up assessments will be performed at 2, 6, and 12 weeks postoperatively, and will include pain medication utilization (morphine milligram equivalents), pain scores, and other substance use. In addition, overall patient wellness will be evaluated with objective actigraphy measures and patient-reported outcomes. Finally, a survey of patient understanding of risks of opioid use and misuse will be collected, to assess the influence of LCS opioid education. DISCUSSION: There is limited data on the role of individualized, multimodal, non-pharmacologic, behavioral-based pain management intervention in opioid-related risk-mitigation in high-risk populations, including the orthopedic trauma patients. The findings from this randomized controlled trial will provide scientific and clinical evidence on the efficacy and feasibility of the LCS intervention. Moreover, the final aim will provide early evidence into which patients benefit most from LCS intervention. TRIAL REGISTRATION: ClinicalTrials.gov NCT04154384 . Registered on 11/6/2019 (last updated on 6/10/2021).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Giordano NA, Seilern Und Aspang J, Baker J, et al. The effect of a Life Care Specialist on pain management and opioid-related outcomes among patients with orthopedic trauma: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34838101. doi:10.1186/s13063-021-05841-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。